Genetic and infectious profiles influence cerebrospinal fluid igg abnormality in japanese multiple sclerosis patients

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Yoshimura, Satoshi ^a   Isobe, Noriko ^a   Matsushita, Takuya ^a   Masaki, Katsuhisa ^a   Sato, Shinya ^a   Kawano, Yuji ^a   Ochi, Hirofumi ^b   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; HLA DRB1 ANTIGEN;

ADULT; ALLELE; ARTICLE; BRAIN DAMAGE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID IMMUNOGLOBULIN G ABNORMALITY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HERPES ZOSTER; HUMAN; IMMUNOGLOBULIN G DEFICIENCY; INFECTION; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; VARICELLA ZOSTER VIRUS; ANTIBODY DETECTION; BRAIN RADIOGRAPHY; CHLAMYDIA PNEUMONIAE; CLINICAL FEATURE; GENE LOCUS; HLA DRB1 GENE; IMMUNOGLOBULIN BLOOD LEVEL;

EID: 84899670734     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095367.t001     Document Type: Article

References (50)

1. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372: 1502-1517
2. Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7: 268-277. (Pubitemid 351222732)
3. Swcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359): 214-219.
4. Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, et al. (1996) Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40: 569-574. (Pubitemid 26357880)
5. Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, et al. (1999) HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122:1689-1696. (Pubitemid 29425672)
6. Ono T, Zambenedetti MR, Yamasaki K, Kawano Y, Kamikawaji N, et al. (1998) Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type). Tissue Antigens 52: 539-542. (Pubitemid 29002757)
7. Yoshimura S, Isobe N, Yonekawa T, Matsushita T, Masaki K, et al. (2012) South Japan Multiple Sclerosis Genetics Consortium: genetic and infectious profiles of Japanese multiple sclerosis patients. PLoS ONE 7: e48592.
8. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A (2010) Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 67: 824-830.
9. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV (2010) Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 6: 156-166.
10. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, et al. (1999) Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 46: 6-14. (Pubitemid 29314377)
11. Bagos PG, Nikolopoulos G, Ioannidis A (2006) Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 12: 397-411. (Pubitemid 44132580)
12. Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, et al. (2007) Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 184: 227-331.
13. Li W, Minohara M, Piao H, Matsushita T, Masaki K, et al. (2009). Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult Scler 15: 1411-1421.
14. Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, et al. (2013) Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry 84: 29-34.
15. Link H, Huang YM (2006) Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol180: 17-28. (Pubitemid 44692326)
16. Lechner-Scott J, Spencer B, de Malmanche T, Attia J, Fitzgerald M, et al. (2012) The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler 18: 974-982.
17. Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2: 117-127. (Pubitemid 37443332)
18. Fukazawa T, Kikuchi S, Sasaki H, Hamada K, Hamada T, et al. (1998). The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. J Neurol Sci 158: 209-214. (Pubitemid 28342086)
19. Kikuchi S, Fukazawa T, Niino M, Yabe I, Miyagishi R, et al. (2003) HLArelated subpopulations of MS in Japanese with and without oligoclonal IgG bands. Neurology 60: 647-651. (Pubitemid 36246084)
20. Nakashima I, Fujihara K, Sato S, Itoyama Y (2005) Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis. J Neuroimmunol. 159: 133-136. (Pubitemid 40126186)
21. Siritho S, Prayoonwiwat N (2007) A retrospective study of multiple sclerosis in Siriraj Hospital, Bankok, Thailand. Can J Neurol Sci 34: 99-104. (Pubitemid 46423351)
22. Imrell K, Landtblom AM, Hillert J, Masterman T (2006) Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67: 1062-1064. (Pubitemid 44454606)
23. Romero-Pinel L, Mart?ńez-Yélamos S, Bau L, Matas E, Gubieras L, et al. (2011) Association of HLA-DRB1 15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Eur J Neurol 8: 1258-1262.
24. Stendahl-Brodin L, Link H (1980) Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 43: 102-105. (Pubitemid 10129581)
25. Zeman AZ, Kidd D, McLean BN, Kelly MA, Francis DA, et al. (1996) A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 60: 27-30. (Pubitemid 26013190)
26. Koch M, Heersema D, Mostert J, Teelken A, De Keyser J (2007) Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis. Eur J Neurol 14: 797-800. (Pubitemid 47012193)
27. Siritho S, Freedman MS (2009) The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci 279: 21-25.
28. Lourenco P, Shirani A, Saeedi J, Oger J, Schreiber WE, et al. (2013) Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression. Mult Scler 19: 577-584
29. Nakashima I, Fujihara K, Misu T, Fujimori J, Sato S, et al. (2002) A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands. Mult Scler 8: 459-462. (Pubitemid 35396392)
30. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" . Ann Neurol 58: 840-846. (Pubitemid 41746873)
31. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489. (Pubitemid 43958540)
32. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452. (Pubitemid 14237132)
33. Poser S, Ritter G, Bauer HJ, Grosse-Wilde H, Kuwert EK, et al. (1981) HLAantigens and the prognosis of multiple sclerosis. J Neurol 225: 219-221.
34. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059-2069. (Pubitemid 27493740)
35. Matsuoka T, Matsushita T, Osoegawa M, Ochi H, Kawano Y, et al. (2008) Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 266: 115-125. (Pubitemid 351186531)
36. Isobe N, Yonekawa T, Matsushita T, Kawano Y, Masaki K, (2012) Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica. Mult Scler 18: 1541-1551
37. Laheij RJ, Straatman H, Jansen JB, Verbeek AL (1998) Evaluation of commercially available Helicobacter pylori serology kits: a review. J Clin Microbiol 36: 2803-2809. (Pubitemid 28429395)
38. Hermann C, Graf K, Groh A, Straube E, Hartung T (2002) Comparison of eleven commercial tests for Chlamydia pneumoniaespecific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 40: 1603-1609. (Pubitemid 34493126)
39. Wu JS, Qiu W, Castley A, James I, Joseph J, et al. (2010) Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. J Neurol Sci 288: 63-67.
40. Romero-Pinel L, Mart?ńez-Yélamos S, Bau L, Matas E, Gubieras L, et al. (2011) Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Eur J Neurol 18:1258-1262.
41. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, et al. (2009). Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 132: 250-259.
42. Sellebjerg F, Jensen J, Madsen HO, Svejgaard A (2000) HLA DRB1-1501 and intrathecal inflammation in multiple sclerosis. Tissue Antigens 55: 312-318. (Pubitemid 30237399)
43. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, et al. (2000) HLADR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 48: 211-219. (Pubitemid 30617040)
44. Ishizu T, Kira J, Osoegawa M, Fukazawa T, Kikuchi S, et al. (2009) Research Committee of Neuroimmunological Diseases: Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. J Neurol Sci 280: 22-28.
45. Kuenz B, Lutterotti A, Ehling R, Gneiss C, Haemmerle M, et al. (2008) Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One. 3: e2559.
46. Kamradt T, Goggel R, Erb KJ (2005) Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trend Immun 26: 260-267. (Pubitemid 41556849)
47. Layh-Schmitt G, Bendl C, Hildt U, Dong-Si T, Jüttler E, et al. (2000) Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol 47: 652-655. (Pubitemid 30261903)
48. Derfuss T, Gürkov R, Then Bergh F, Goebels N, Hartmann M, et al. (2001) Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 124: 1325-1335. (Pubitemid 32606094)
49. Saiz A, Marcos MA, Graus F, Vidal J, Jimenez de Anta MT (2001) No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis. J Neurol 248: 617-618. (Pubitemid 32695804)
50. Sotgiu S, Piana A, Pugliatti M, Sotgiu A, Deiana GA, et al. (2001) Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls. Mult Scler 7: 371-374 (Pubitemid 33138347)